DUBLIN--(BUSINESS WIRE)--The "Liquid Biopsies 2019" conference has been added to ResearchAndMarkets.com's offering.
Liquid Biopsies 2019 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.
There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring, and minimal residual disease detection.
This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations at both conferences, co-located exhibit hall, and extensive networking opportunities.
Agenda
DAY 1 - WEDNESDAY, 27 MARCH 2019
08:00 - Conference Registration, Materials Pick-Up, Morning Coffee and Breakfast Pastries
08:45 - Conference Chair
09:00 - Keynote Presentation
09:30 - Keynote Presentation
10:00 - Coffee Break and Networking in the Exhibit Hall
10:45 - Keynote Presentation
11:15 - Conference Chair
11:45 - Keynote Presentation
12:15 - Networking Lunch in the Exhibit Hall and Poster Viewing
14:00 - Ultrasensitive Detection of Cancer Using cfDNA Methylation Sequencing
14:30 - Low Coverage, Genome-Wide Sequencing of Cell-Free DNA Enables the Monitoring of Response to Immunotherapy in Cancer Patients
15:00 - Ultra-Sensitive Mutational Analysis in Cell-Free DNA by Digital PCR and NGS Technologies
15:30 - Afternoon Coffee Break in the Exhibit Hall
16:00 - Early Cancer Detection in Plasma by Methylation Haplotyping
16:30 - Monitoring Recurrence With Personalized ctDNA Assays
17:00 - cfDNA Analysis in ALK-positive NSCLC Patients and Potential Clinical Utility
18:00 - Networking Reception with Beer and Wine in the Exhibit Hall
19:00 - Close of Day 1 of the Conference
DAY 2 - THURSDAY, 28 MARCH 2019
08:30 - Morning Coffee and Breakfast Pastries Served in the Exhibit Hall
09:00 - Keynote Presentation
09:30 - Circulating Tumor DNA Analyses in Lung Cancer
10:00 - Keynote Presentation
11:00 - Circulating Biomarkers: The New Nanotube-CTC-Microarray Chip for Clinical Impact
11:30 - Keynote Presentation
12:00 - Networking Lunch in the Exhibit Hall and Poster Viewing
13:00 - Quantitative Detection of Gene Rearrangements Using Circulating Tumor Cells Purified by a Covalent Chemistry-Enabled Platform
13:30 - Keynote Presentation
14:00 - Keynote Presentation
14:30 - Title to be Confirmed
15:00 - Characterizing Cell-Free Circulating RNA - A Dream or a Reality?
15:30 - Afternoon Coffee Break in the Exhibit Hall
16:00 - Keynote Presentation
16:30 - Circulating Tumor DNA Methylation Markers for Diagnosis and Prognosis of Hepatocellular Carcinoma
17:30 - Industry Panel Discussion Focusing on Circulating Biomarkers & Liquid Biopsy
18:15 - Close of Day 2 of the Conference Track
DAY 3 - FRIDAY, 29 MARCH 2019
08:30 - Morning Coffee and Breakfast Pastries Served in the Exhibit Hall
09:00 - Highly Sensitive Direct Quantification of cfmiRNAs for Biomarker Profiling by Next Generation Sequencing (NGS)
09:30 - Applying ctDNA and Other Liquid Biopsy Technologies for Oncology Translational and Clinical Research
10:00 - BloodPAC: Establishing Standards to Accelerate Development and Approval of Liquid Biopsy Technology
10:30 - Toward Perfect Detection of Un-amplified Biomarkers with Single-Molecule Kinetic Fingerprinting
11:00 - Keynote Presentation
For more information about this conference visit https://www.researchandmarkets.com/research/38hk3x/3day_conference?w=4
